Ozempic OverviewSemaglutide (USAN; trade name Ozempic) is a pharmaceutical drug in development by a Danish company Novo Nordisk for the treatment of type 2 diabetes. It is marketed by the name Ozempic. As a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by increasing the production of insulin. It was discovered in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide. Clinical trials were started in 2015, and phase 3 was completed ...
Read more Ozempic Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Semaglutide
Recent Ozempic Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 2mg/1.5ml (1.34mg/ml)
NDC Database Records for Ozempic: (2 results)Sorted by National Drug Code
- 0169-4132 Ozempic 1.34 mg/ml Subcutaneous Injection, Solution by Novo Nordisk
- 0169-4136 Ozempic 1.34 mg/ml Subcutaneous Injection, Solution by Novo Nordisk